PLC Beta2 Polyclonal Antibody, 50ul Drug Development and Evaluation which is activated by binding

which is activated by binding of small GTPases such as CDC42 to an N-terminal regulatory domain

The relaxin 3 is a precursor that is proteolytically processed to generate a heterodimeric mature form consisting A and B chains interlinked by disulfide bonds

Mutations in RPS19 cause Diamond-Blackfan anemia (DBA)

Ubiquitin-like molecules (UBLs)

PLC Beta2 Polyclonal Antibody, 50ul Drug Development and Evaluation which is activated by bindingPLCB2 (Phospholipase C Beta 2) is a Protein Coding gene. Diseases associated with PLCB2 include prostate leiomyosarcoma. Among its related pathways are cGMP PKG signaling pathway and African trypanosomiasis. GO annotations related to this gene include calcium ion binding and phosphoric diester hydrolase activity. An important paralog of this gene is PLCB3.